Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT06702657Not yet recruiting
Randomised, open-label trial in ischemic stroke and intracranial atherosclerosis (ICAD) (2 arms), sponsored by Changhai Hospital. Primary endpoint: Modified Rankin Scale Score at 90 days. Planned start Mar 2025; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT06702657.